🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 59564R203 (prev. 59564R104 )
- Market Cap
- Micro Cap
- ADR Ratio
- 1:100000
- Previous Symbol
- MTP (changed 3/24/2023)
- Previous Name
- Midatech Pharma Plc
Business: Biodexa Pharmaceuticals PLC is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain.
Notes: Effective on March 3, 2020 -- Midatech's existing ordinary shares of 0.005p each in the capital of the Company ("Existing Ordinary Shares") will be consolidated on a one for 20 basis into new ordinary shares of 0.1p each in the capital of the Company ("New Ordinary Shares"). Admission to trading of the New Ordinary Shares, with CUSIP GB00BKT14T00, pursuant to Rule 6 of the AIM Rules for Companies is expected to begin on March 3, 2020. Also, the ratio of the Company's American Depositary Receipts ("ADRs") will change from one ADR representing 20 Existing Ordinary Shares to one ADR representing five New Ordinary Shares, with new CUSIP 59564R302. No fractional ADRs will be allocated. The aggregate fractions, if any, will be sold and the net proceeds will be distributed to the entitled ADR holder. The Company depositary, Deutsche Bank Trust Company Americas, will contact ADR holders and arrange for the exchange of their existing ADRs for new ADRs.
Company Contact
- CEO
- Stephen Stamp
- CFO
- Stephen Stamp
- Investor Relations
- Alyssa Factor · 860-573-9637 · afactor@edisongroup.com